Literature DB >> 20606487

Moderate chronic kidney disease in women is associated with fracture occurrence independently of osteoporosis.

Sinead Kinsella1, Shawn Chavrimootoo, Michael G Molloy, Joseph A Eustace.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is associated with increased risk of fragility fracture but whether this is independent of osteoporosis is unclear.
METHODS: We conducted a retrospective cross-sectional study of 1,702 female patients referred for dual-energy X-ray absorptiometry (DXA) scanning (Lunar IDXA) between September 2006 and April 2007. Estimated glomerular filtration rate (eGFR; ml/min/1.73 m(2)) by Modification of Diet in Renal Disease was calculated within 1 year (median interval 4 weeks) of the DXA scan. The independent association of self-reported fracture occurrence with eGFR category was assessed using multivariate logistic regression.
RESULTS: Mean age (SD) was 61.7 (10.8) years; mean eGFR (SD) was 68.8 (12.2). The percentages of subjects with an eGFR of 75-89, 60-74, 30-59 and <30 was 34, 45, 20 and 0.8%, respectively. Forty-seven percent had osteoporosis. Mean T scores for the above eGFR categories were -2.2, -2.3, -2.5 and -3.0, respectively (p trend <0.001). Osteoporosis was significantly associated with eGFR on univariate analysis but not following adjustment for age. The percentage of patients with a fracture (29%) and with multiple prior fractures (3.5%) was higher at lower eGFR (p < 0.001, χ(2) test). The adjusted odds ratios (95% confidence interval) of any prior fracture for eGFR 75-89, 60-74 and 30-59 were 1.0 (reference), 1.2 (0.9-1.6) and 1.4 (1.0-1.9), respectively, adjusting simultaneously for age, T score, risk factors and treatment for osteoporosis.
CONCLUSION: Moderate CKD is a significant independent predictor of fracture occurrence.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20606487     DOI: 10.1159/000317207

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  10 in total

1.  Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without renal dysfunction: a retrospective study.

Authors:  Jun Iwamoto; Yoshihiro Sato; Mitsuyoshi Uzawa; Tsuyoshi Takeda; Hideo Matsumoto
Journal:  Drugs Aging       Date:  2012-02-01       Impact factor: 3.923

Review 2.  Hyponatremia and bone: an emerging relationship.

Authors:  Ewout J Hoorn; George Liamis; Robert Zietse; M Carola Zillikens
Journal:  Nat Rev Endocrinol       Date:  2011-10-25       Impact factor: 43.330

3.  Estimated GFR and fracture risk: a population-based study.

Authors:  Meghan J Elliott; Matthew T James; Robert R Quinn; Pietro Ravani; Marcello Tonelli; Luz Palacios-Derflingher; Zhi Tan; Braden J Manns; Gregory A Kline; Paul E Ronksley; Brenda R Hemmelgarn
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 8.237

4.  Bone metabolism subgroups identified as hip fracture patients via clustering.

Authors:  Evangelia Papakitsou; Ioanna Paspati; Stavroula Rizou; George P Lyritis
Journal:  Hormones (Athens)       Date:  2021-02-23       Impact factor: 2.885

Review 5.  Reduced kidney function is associated with BMD, bone loss and markers of mineral homeostasis in older women: a 10-year longitudinal study.

Authors:  L Malmgren; F McGuigan; A Christensson; K E Akesson
Journal:  Osteoporos Int       Date:  2017-10-16       Impact factor: 4.507

6.  Hip fracture incidence and mortality in chronic kidney disease: the GLOMMS-II record linkage cohort study.

Authors:  Lynn Robertson; Corrinda Black; Nick Fluck; Sharon Gordon; Rosemary Hollick; Huong Nguyen; Gordon Prescott; Angharad Marks
Journal:  BMJ Open       Date:  2018-04-12       Impact factor: 2.692

7.  The association between chronic kidney disease, falls, and fractures: a systematic review and meta-analysis.

Authors:  N A Goto; A C G Weststrate; F M Oosterlaan; M C Verhaar; H C Willems; M H Emmelot-Vonk; M E Hamaker
Journal:  Osteoporos Int       Date:  2019-11-12       Impact factor: 4.507

8.  Relationship between bone mineral density and moderate to severe chronic kidney disease among general population in Korea.

Authors:  Jun-Pyo Myong; Hyoung-Ryoul Kim; Jung-Wan Koo; Chung Yill Park
Journal:  J Korean Med Sci       Date:  2013-03-27       Impact factor: 2.153

9.  Effects of raloxifene on bone metabolism in hemodialysis patients.

Authors:  Jun Iwamoto
Journal:  Int J Endocrinol Metab       Date:  2012-06-30

10.  Kidney function and its association to imminent, short- and long-term fracture risk-a longitudinal study in older women.

Authors:  L Malmgren; F E McGuigan; A Christensson; K E Akesson
Journal:  Osteoporos Int       Date:  2019-11-21       Impact factor: 4.507

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.